Dermatology Times, November 2018 (Vol. 39, No. 11)

Classifying diabetic foot ulcers

November 14, 2018

Dermatologists must be able to distinguish between infected and noninfected diabetic foot ulcers because whether or not a DFU is infected can help determine treatment protocol, says Warrent S. Joseph, D.P.M, FIDSA. 

Role of protease targets in wound healing uncertain

November 14, 2018

Protease modulating therapies are used to assist in venous leg ulcer closure, but a recent review suggests that physicians should reexamine the biomarker's role in targeted chronic wound healing therapies.

Verrica develops a solution for common warts

November 13, 2018

Dr. Matt Davidson, Ph.D., wanted to find an effective and affortable treatment for the recurring common warts on his hands, which has lead him to become one of the youngest, if not youngest, pharmaceutical company pioneers in the country. 

Sarecycline approved for moderate-to-severe acne

November 13, 2018

The Food and Drug Administration (FDA) approved sarecycline (Seysara, Almirall, S.A.) in October for the treatment of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older, according to a company news release.

Leg ulcers that require punch biopsies

November 12, 2018

Victor Desmond Mandel, M.D. and colleagues describe a reconstruction strategy for chronic infected neoplastic ulcers of the lower extremities using a dermal matrix and a unique postoperative dressing protocol.

Surgical treatment for basal cell carcinomas still the best bet

September 17, 2018

There are many non-surgical treatments for basal cell carcinomas, but a physician reporting at EADV last week said new treatments should be compared against surgery, which has the highest cure rate and lowest rate of recurrence.

Treating moles and melanoma during pregnancy

September 17, 2018

A pregnancy-associated melanoma (PAM) prognosis does not appear to be worse than melanoma in non-pregnant controls, researchers reported at EADV. Nonetheless, measures should be taken to protect the fetus in the treatment and imaging of PAM.

Advent of immunotherapy may require a new, expanded role for dermatologists

September 14, 2018

With immunotherapy as a key treatment for melanoma, dermatologists should be prepared to treat its cutaneous side effects and refer for adrenal sufficiency, uveitis, thyroid disease and other non-cutaneous side effects.